dm+d
42082003
Articles
Vancomycin: informing intrathecal risk assessment
11 August 2022Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
How should medicines be dosed in children who are obese?
28 May 2021Review on how to calculate medicine doses in children who are obese which includes a table on commonly prescribed medicines.
Choosing between oral vancomycin options
18 May 2021Local decision makers should choose between the options for giving vancomycin orally. Licensing status and other factors affect decision making.
Medicine Compliance Aid Stability
Vancocin / MatrigelFlynn Pharma Ltd
Flynn Pharma Ltd
Vancocin / Matrigel
Capsules 125mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Powder is hygroscopic. Store in airtight container. Maximum 7 days in MCA.
22 November 2022
Lactation Safety Information
Not absorbed from the infant's GI tract
Small amounts in breast milk
24 September 2020